US20090127155A1 - Packaging for unitary dosage items - Google Patents
Packaging for unitary dosage items Download PDFInfo
- Publication number
- US20090127155A1 US20090127155A1 US11/985,710 US98571007A US2009127155A1 US 20090127155 A1 US20090127155 A1 US 20090127155A1 US 98571007 A US98571007 A US 98571007A US 2009127155 A1 US2009127155 A1 US 2009127155A1
- Authority
- US
- United States
- Prior art keywords
- base unit
- unitary dosage
- package
- box
- unit box
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000004806 packaging method and process Methods 0.000 title abstract description 16
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims abstract description 15
- 229910052760 oxygen Inorganic materials 0.000 claims abstract description 15
- 239000001301 oxygen Substances 0.000 claims abstract description 15
- 239000011087 paperboard Substances 0.000 claims description 22
- 238000007373 indentation Methods 0.000 claims description 12
- 229930003316 Vitamin D Natural products 0.000 claims description 10
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 claims description 10
- 235000019166 vitamin D Nutrition 0.000 claims description 10
- 239000011710 vitamin D Substances 0.000 claims description 10
- 150000003710 vitamin D derivatives Chemical class 0.000 claims description 10
- 229940046008 vitamin d Drugs 0.000 claims description 10
- 235000021388 linseed oil Nutrition 0.000 claims description 8
- 239000000944 linseed oil Substances 0.000 claims description 8
- 239000013047 polymeric layer Substances 0.000 claims description 7
- 238000007789 sealing Methods 0.000 claims description 7
- JBYXPOFIGCOSSB-GOJKSUSPSA-N 9-cis,11-trans-octadecadienoic acid Chemical group CCCCCC\C=C\C=C/CCCCCCCC(O)=O JBYXPOFIGCOSSB-GOJKSUSPSA-N 0.000 claims description 6
- 239000004480 active ingredient Substances 0.000 claims description 6
- 229940108924 conjugated linoleic acid Drugs 0.000 claims description 6
- 235000015872 dietary supplement Nutrition 0.000 claims description 6
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 claims description 6
- 239000007897 gelcap Substances 0.000 claims description 5
- 239000007788 liquid Substances 0.000 claims description 5
- 235000020660 omega-3 fatty acid Nutrition 0.000 claims description 5
- 229940012843 omega-3 fatty acid Drugs 0.000 claims description 5
- CYQFCXCEBYINGO-IAGOWNOFSA-N delta1-THC Chemical group C1=C(C)CC[C@H]2C(C)(C)OC3=CC(CCCCC)=CC(O)=C3[C@@H]21 CYQFCXCEBYINGO-IAGOWNOFSA-N 0.000 claims description 4
- 239000010410 layer Substances 0.000 claims description 4
- 230000006378 damage Effects 0.000 abstract description 6
- 230000003413 degradative effect Effects 0.000 abstract description 2
- 239000006187 pill Substances 0.000 description 30
- 239000002775 capsule Substances 0.000 description 26
- 230000008901 benefit Effects 0.000 description 8
- 239000000463 material Substances 0.000 description 6
- 239000003921 oil Substances 0.000 description 6
- 235000019198 oils Nutrition 0.000 description 6
- 230000009286 beneficial effect Effects 0.000 description 5
- 229940079593 drug Drugs 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 4
- 235000014113 dietary fatty acids Nutrition 0.000 description 4
- 239000000194 fatty acid Substances 0.000 description 4
- 229930195729 fatty acid Natural products 0.000 description 4
- 150000004665 fatty acids Chemical class 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 230000001681 protective effect Effects 0.000 description 4
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 description 3
- 239000003086 colorant Substances 0.000 description 3
- 238000010276 construction Methods 0.000 description 3
- 235000020673 eicosapentaenoic acid Nutrition 0.000 description 3
- 229960005135 eicosapentaenoic acid Drugs 0.000 description 3
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- MJYQFWSXKFLTAY-OVEQLNGDSA-N (2r,3r)-2,3-bis[(4-hydroxy-3-methoxyphenyl)methyl]butane-1,4-diol;(2r,3r,4s,5s,6r)-6-(hydroxymethyl)oxane-2,3,4,5-tetrol Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O.C1=C(O)C(OC)=CC(C[C@@H](CO)[C@H](CO)CC=2C=C(OC)C(O)=CC=2)=C1 MJYQFWSXKFLTAY-OVEQLNGDSA-N 0.000 description 2
- YUFFSWGQGVEMMI-JLNKQSITSA-N (7Z,10Z,13Z,16Z,19Z)-docosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCCCC(O)=O YUFFSWGQGVEMMI-JLNKQSITSA-N 0.000 description 2
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 2
- 235000021294 Docosapentaenoic acid Nutrition 0.000 description 2
- 229930003427 Vitamin E Natural products 0.000 description 2
- MBMBGCFOFBJSGT-KUBAVDMBSA-N all-cis-docosa-4,7,10,13,16,19-hexaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 description 2
- 235000012716 cod liver oil Nutrition 0.000 description 2
- 239000003026 cod liver oil Substances 0.000 description 2
- 235000020669 docosahexaenoic acid Nutrition 0.000 description 2
- 235000021323 fish oil Nutrition 0.000 description 2
- 235000004426 flaxseed Nutrition 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 238000002372 labelling Methods 0.000 description 2
- 235000020665 omega-6 fatty acid Nutrition 0.000 description 2
- 229940033080 omega-6 fatty acid Drugs 0.000 description 2
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 description 2
- 239000003826 tablet Substances 0.000 description 2
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 description 2
- 235000019165 vitamin E Nutrition 0.000 description 2
- 229940046009 vitamin E Drugs 0.000 description 2
- 239000011709 vitamin E Substances 0.000 description 2
- DVSZKTAMJJTWFG-SKCDLICFSA-N (2e,4e,6e,8e,10e,12e)-docosa-2,4,6,8,10,12-hexaenoic acid Chemical compound CCCCCCCCC\C=C\C=C\C=C\C=C\C=C\C=C\C(O)=O DVSZKTAMJJTWFG-SKCDLICFSA-N 0.000 description 1
- JKQXZKUSFCKOGQ-JLGXGRJMSA-N (3R,3'R)-beta,beta-carotene-3,3'-diol Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-JLGXGRJMSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- GZJLLYHBALOKEX-UHFFFAOYSA-N 6-Ketone, O18-Me-Ussuriedine Natural products CC=CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O GZJLLYHBALOKEX-UHFFFAOYSA-N 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 244000017106 Bixa orellana Species 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- 241000239366 Euphausiacea Species 0.000 description 1
- 239000011786 L-ascorbyl-6-palmitate Substances 0.000 description 1
- QAQJMLQRFWZOBN-LAUBAEHRSA-N L-ascorbyl-6-palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](O)[C@H]1OC(=O)C(O)=C1O QAQJMLQRFWZOBN-LAUBAEHRSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- QNVSXXGDAPORNA-UHFFFAOYSA-N Resveratrol Natural products OC1=CC=CC(C=CC=2C=C(O)C(O)=CC=2)=C1 QNVSXXGDAPORNA-UHFFFAOYSA-N 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- LUKBXSAWLPMMSZ-OWOJBTEDSA-N Trans-resveratrol Chemical compound C1=CC(O)=CC=C1\C=C\C1=CC(O)=CC(O)=C1 LUKBXSAWLPMMSZ-OWOJBTEDSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- JKQXZKUSFCKOGQ-LQFQNGICSA-N Z-zeaxanthin Natural products C([C@H](O)CC=1C)C(C)(C)C=1C=CC(C)=CC=CC(C)=CC=CC=C(C)C=CC=C(C)C=CC1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-LQFQNGICSA-N 0.000 description 1
- QOPRSMDTRDMBNK-RNUUUQFGSA-N Zeaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCC(O)C1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C QOPRSMDTRDMBNK-RNUUUQFGSA-N 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 239000012790 adhesive layer Substances 0.000 description 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 1
- JKQXZKUSFCKOGQ-LOFNIBRQSA-N all-trans-Zeaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C JKQXZKUSFCKOGQ-LOFNIBRQSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- 235000012665 annatto Nutrition 0.000 description 1
- 239000010362 annatto Substances 0.000 description 1
- 235000010385 ascorbyl palmitate Nutrition 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011651 chromium Substances 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000004035 construction material Substances 0.000 description 1
- 238000010411 cooking Methods 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 229940090949 docosahexaenoic acid Drugs 0.000 description 1
- KAUVQQXNCKESLC-UHFFFAOYSA-N docosahexaenoic acid (DHA) Natural products COC(=O)C(C)NOCC1=CC=CC=C1 KAUVQQXNCKESLC-UHFFFAOYSA-N 0.000 description 1
- 239000008157 edible vegetable oil Substances 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 150000004668 long chain fatty acids Chemical class 0.000 description 1
- 235000012680 lutein Nutrition 0.000 description 1
- 229960005375 lutein Drugs 0.000 description 1
- 239000001656 lutein Substances 0.000 description 1
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 description 1
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 238000002483 medication Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 239000002417 nutraceutical Substances 0.000 description 1
- 235000021436 nutraceutical agent Nutrition 0.000 description 1
- 235000011837 pasties Nutrition 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 239000011253 protective coating Substances 0.000 description 1
- 235000021283 resveratrol Nutrition 0.000 description 1
- 229940016667 resveratrol Drugs 0.000 description 1
- 235000020748 rosemary extract Nutrition 0.000 description 1
- 229940092258 rosemary extract Drugs 0.000 description 1
- 239000001233 rosmarinus officinalis l. extract Substances 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 238000010008 shearing Methods 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 235000019149 tocopherols Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940046001 vitamin b complex Drugs 0.000 description 1
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 description 1
- 235000010930 zeaxanthin Nutrition 0.000 description 1
- 239000001775 zeaxanthin Substances 0.000 description 1
- 229940043269 zeaxanthin Drugs 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
- QUEDXNHFTDJVIY-UHFFFAOYSA-N γ-tocopherol Chemical class OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 QUEDXNHFTDJVIY-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
- B65D83/00—Containers or packages with special means for dispensing contents
- B65D83/04—Containers or packages with special means for dispensing contents for dispensing annular, disc-shaped, spherical or like small articles, e.g. tablets or pills
- B65D83/0445—Containers or packages with special means for dispensing contents for dispensing annular, disc-shaped, spherical or like small articles, e.g. tablets or pills all the articles being stored in individual compartments
- B65D83/0463—Containers or packages with special means for dispensing contents for dispensing annular, disc-shaped, spherical or like small articles, e.g. tablets or pills all the articles being stored in individual compartments formed in a band or a blisterweb, inserted in a dispensing device or container
Definitions
- the present invention provides packaging for unitary dosage items, such as capsules or tablets in a blister pack, where each sheet of the blister pack is individually wrapped in a paperboard sleeve to form an easily portable unit.
- unitary dosage items such as capsules or tablets in a blister pack
- each sheet of the blister pack is individually wrapped in a paperboard sleeve to form an easily portable unit.
- portable units are packaged in a box for the consumer.
- Such packaging is particularly useful for oxygen- and light-sensitive dosage items, for example, omega-3-fatty acid, vitamin D, flax oil or conjugated linoleic acid nutritional supplements.
- Pill boxes have existed for a very long time, for people to conveniently carry.
- Reminder pill boxes are also known, such as a container with 7 compartments labeled with the days of the week, so a person can remember whether they took their dosage for the day.
- Other pill boxes have multiple compartments within each day so that a person can tell whether they took a given unit dosage for a certain time of day.
- the pills in pill boxes of the art are exposed to air and light as they are transferred from a reservoir bottle to the pill box, and they can contact each other, possibly breaking, while the pill box is shaken with the motion of transporting the pill box with a person.
- Protective packaging for pills and tablets most commonly includes bottles where multiple pills and tablets are jumbled into a single bottle, often with cottony fill at the top and a lid. In some cases, the patient has difficulty opening a pill bottle, or difficulty in handling a large, cumbersome bottle. This type of packaging is somewhat limiting for breakable, fragile pills and capsules.
- a single container holding several doses with one opening lid also leads to a shorter shelf life for oxygen-sensitive pills and capsules.
- oxygen-sensitive means that the ingredients of the pills or capsules are more rapidly degraded over time upon exposure to oxygen than non-oxygen-sensitive pills or capsules.
- the bottle is opened to remove a single dose, the remainder of product is exposed to oxygen in advance of its own consumption, often multiple times.
- Dosage-reminder packaging for tablets or capsules is known in the art.
- Several types of dosage-reminding packaging are blister packages with a certain arrangement of pills or capsules on the card, including some with labeling on the package for date or time for taking a particular pill or capsule.
- An example is the monthly package for birth control pills.
- Blister packaging is known to protect oxygen-sensitive tablets or capsules.
- the entire enclosure for the tablet or capsule should be impermeable to oxygen. This typically includes both the formed film side (often shaped to receive the tablet or capsule) and the sealing membrane side (typically planar).
- pills, tablets and capsules are fragile and can be physically damaged during storage and transport.
- oral unit dosages of liquids are sometimes enclosed in a capsule. These liquid capsules may leak in storage if they get crushed. Pills or tablets may also be fragile or subject to damage by crushing or contact during transport and storage.
- Blister packaging itself can provide some protection against crushing.
- Some medications or nutrients are sensitive to light.
- the active ingredient can be degraded upon exposure to light of a certain wavelength.
- this problem is often minimized by using a dark-tinted bottle for medication or nutrient storage.
- a protective coating that lets through less light is provided for the medication, on the unit dosage itself (e.g. opaque capsules).
- the present invention provides an alternative solution to the problem of stability of unit-dose blister packaging, while also solving the problem of easy portability and protection of fragile, oxygen-sensitive or light-sensitive pills or capsules.
- the present invention contemplates a convenient package for unitary dosage items that permits relatively small amounts of fragile or sensitive nutrients or medication to be easily portable.
- the package is a typical blister package made up of a polymeric layer with indentations for a plurality of unitary dosage items that is sealed in with a substantially planar adhesive layer that seals off each indentation, resulting in a plurality of individual compartments, each containing a unitary dosage of the unitary dosage items.
- the blister package may provide protection of each unitary dosage item from exposure to oxygen prior to use by the consumer.
- the blister package slides into a paperboard sleeve for physical protection of the blister package and the items contained therein.
- the invention optionally contemplates that the paperboard sleeve can provide a light barrier for light sensitive unitary dosage items.
- the package according to the present invention includes the paperboard sleeve together with the blister package that encloses the unitary dosage items.
- a contemplated fragile unitary dosage item is a gel cap containing a liquid nutritional supplement or a pharmaceutical active ingredient.
- One such contemplated unitary dosage item is a gel cap containing an edible oil and a nutritional supplement or a pharmaceutical active ingredient.
- Some of the contemplated nutritional supplements or pharmaceutical active ingredients include a polyunsaturated fatty acid compound having a carbon chain 16 carbons in length where at least one pair of double bonds in that chain are in a conjugated position, vitamin D, flax oil, the polyunsaturated fatty acid that is conjugated linoleic acid, the flax oil component that is omega-3 fatty acid.
- the blister package contains a convenient number of unitary dosage items to provide a reminder to the consumer as to whether a particular dose has been taken or when the next dose should be taken.
- an inner unit package of the present invention contains several unit dosages of the pill or capsules to last for a short period of time.
- the sleeve of the inner unit package provides a shield for light-sensitive pills or tablets to prolong their stability.
- the outer package is of a convenient size and that it contains several easily portable inner unit packages.
- the sleeve of the inner unit package provides protection against physical destruction (e.g. crushing or breakage) of the pills or tablets.
- FIG. 1 represents in FIG. 1A an elevated view of an inner blister pack of a shaped sheet with recesses shaped to receives the pills or capsules in dosage amounts, and an essentially planar sheet that seals the pills or capsules into the recesses.
- FIG. 1B shows the blister pack in position inside the sleeve.
- FIG. 2 represents an inner sleeve formed out of a folded, single sheet of paperboard.
- FIG. 2A shows an overhead view of the single sheet that is folded and glued along edges 10 and 11 to form a paperboard sleeve, as shown in FIG. 2B from an elevated view.
- FIG. 3 represents an outer box formed out of a folded, single sheet of paperboard.
- FIG. 3A shows an overhead view of the single sheet that is folded to form the outer box as shown in FIG. 3B from an elevated view.
- the present invention provides an alternative solution to packaging for a plurality of unitary dosage items that is convenient for a user to carry with them.
- the easily portable package contains a number of unitary dosage items that will remind a user of which dosages have been administered.
- the present invention is particularly useful for unitary dosages of items whose stability or shelf life may be enhanced by decrease of exposure to degradative influences, such as light, oxygen or physical destruction.
- the present invention contemplates a package for a plurality of unitary dosage items that is a blister package.
- the blister package is constructed using methods and materials known in the art.
- An example is shown in FIG. 1 .
- such blister packages typically comprise a polymeric layer that is substantially a planar rectangle with a plurality of indentations of regular depth for storing said unitary dosage items.
- FIG. 1A An example of a blister package ( 1 ) is shown in FIG. 1A ;
- FIG. 1B shows the blister package inserted into the sleeve ( 5 ).
- the present invention further contemplates a protective sleeve for the blister package, an example of which is shown in FIG. 2 .
- the paperboard sleeve is constructed using methods and materials known in the art.
- a rectangular prismatic paperboard sleeve ( 5 ) is made up of a single sheet of substantially rectangular paperboard.
- the paperboard is folded four times ( 6 , 7 , 8 , 9 ) with two opposing sides of the rectangle adhered together to form a sleeve that has substantially rectangular sides, two wide and two narrow in opposed pairs, with two substantially rectangular openings on opposite ends of the sleeve from each other.
- the two wide sides of the sleeve are slightly wider than the substantially planar rectangle of the blister pack and the two narrow sides of the sleeve are slightly wider than the indentation depth of the blister pack.
- the slightly larger size of the sleeve permits the paperboard sleeve to encompass the blister pack to form the package for the plurality of unitary dosage items, but it should not be so much larger that the package does not remain in the sleeve during transportation.
- Contemplated sleeves may also be constructed in multiple parts rather than folded from a single sheet.
- Contemplated sleeves may also be constructed from cardstock or heavier cardboard, of various thicknesses, colors, weights, corrugation, or plastic. However, it should be noted that in embodiments for protecting from physical damage from shearing or crushing forces, stronger materials for sleeves are contemplated. In a contemplated embodiment, the paperboard sleeve is from 0.2 to 0.5 millimeters thick.
- sleeve construction material blocks 50 percent or more of the sun's ultraviolet rays, preferably more than 80 percent, and in a particularly preferred embodiment, a contemplated material blocks 100 percent of the sun's ultraviolet rays.
- the unitary dosage items that would benefit from the contemplated packaging include liquids and solids including pastes and oils.
- Contemplated benefiting unitary dosage items include fragile items, such as capsules or tablets that may be crushed or burst.
- Contemplated benefiting unitary dosage items also include sensitive items, such as those sensitive to oxygen or light. Examples of such sensitive items include vitamin D, linoleic acid, particularly conjugated linoleic acid, flax oil or any of its long chain fatty acid oil components.
- a particular problem addressed by the present invention is that many of the forms of vitamin D commercially available are not bioavailable to a body. This has led to a great deal of confusion in the art pertaining to vitamin D, as to whether vitamin D shows beneficial effects to humans, and how much should be administered to show those beneficial effects. Workers with the present inventors have found that only a fresh form of vitamin D, as a pasty oil, has proven itself to show beneficial effects.
- fatty acids have a short shelf life, going rancid or otherwise degrading rather quickly.
- examples include omega-3 and omega-6 fatty acids, cod liver oil, fish oil, linoleic acid, conjugated linoleic acid, and flaxseed oil.
- the present invention permits the provision of a longer shelf life form of oils or their useful components, including fatty acids, by providing protection from light and oxygen; and also by permitting easy portability of unitary dosage amounts.
- flax seed users it is common for flax seed users to store the seeds in the refrigerator or freezer to prolong the shelf life, and then to put the seeds only on already-cooked foods or raw foods, since the cooking process degrades the beneficial oil components.
- Gel caps of flaxseed oil are presently sold in large jars.
- Contemplated unitary dosage items include pills or capsules (including gel caps and two-piece hard gel capsules) that includes a nutritional supplement or a pharmaceutical active ingredient; fragile items; items sensitive to oxygen; items sensitive to light; vitamin D; conjugated linoleic acid; omega-3 fatty acid; flax oil; cod liver oil, fish oil, and omega-6 fatty acid.
- preferred fatty acids contained in a unitary dosage item include eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), docosapentaenoic acid (DPA), and alpha linolenic acid (ALA), typically from fish or marine sources, flax seed, krill or algae.
- preferred fatty acid concentrations in mg of EPA:DHA per gram of oil include 250:450; 200:600; 500:200 and 400:200.
- Typical capsule sizes include 250 mg, 500 mg, 600 mg, and 1000 mg.
- Typical pill or capsule ingredient sources or types include vegetarian, bovine, porcine, synthetic and chewable.
- excipients include those well known in the art, typically emulsifiers such as lecithin and beeswax; stabilizers such as vitamin E, tocopherols, ascorbyl palmitate, and rosemary extract; and coloring agents including natural coloring agents such as annatto (for example in the capsule coating).
- emulsifiers such as lecithin and beeswax
- stabilizers such as vitamin E, tocopherols, ascorbyl palmitate, and rosemary extract
- coloring agents including natural coloring agents such as annatto (for example in the capsule coating).
- Other contemplated additives include: minerals, including magnesium, zinc, chromium, calcium and selenium; vitamins, including beta-carotene, vitamin A, vitamin D, vitamin E, and vitamin B-complex; and nutraceuticals, including lutein, zeaxanthin, and resveratrol.
- the packaging provides a convenient reminder of when pills have been or should be taken, or a convenient number of doses.
- convenient packaging may provide a package where each row of the blister package contains 7 indentations for storing one week's worth of unitary dosage items. The number of rows may correspond to the number of weeks in a month. Or, if multiple doses are to be taken in a single day, a contemplated embodiment has rows representing different times of day, and a weeks worth of columns. It is to be understood that each dosage amount and frequency will dictate a variety of convenient arrangements of doses in a single blister pack. For example, in an embodiment where two unitary dosage items are to be taken each day, and each row of the blister package contains 14 indentations of regular depth for storing one week's worth of unitary dosage items.
- the blister package contains a convenient number of unitary dosage items to provide a reminder to the consumer as to whether a particular dose has been taken or when the next dose should be taken.
- the rows and columns of the blister package or the labeling thereupon provide a reminder to the consumer as to whether or not a particular unitary dosage item has been consumed.
- a blister pack may have a row containing seven indented chambers for a unitary dosage items that should be taken once a day. The blister pack may then have from one to four such rows to provide sufficient conveniently portable doses for a week or a month.
- a unitary dosage item should be taken three times each day. Then it may be convenient to provide a blister package that has three rows containing seven doses, so that each day, one dose is taken from each of the three rows.
- a package for a plurality of unitary dosage items according the present invention is stacked together with a number of like packages inside an outer package.
- the outer package is constructed by any of the many known methods common in the art. Simple boxes for holding several contemplated packages for a plurality of unitary dosage items are contemplated, preferably sized to hold a number of packages that are convenient for the end-user. Dispenser packages are also contemplated that permit simple removal of a single contemplated package for a plurality of unitary dosage items.
- the outer package is conveniently constructed of a folded single piece of paperboard that has a substantially rectangular base unit that folds to form a base unit box ( 16 ).
- the box lid is a self-lid, which is a substantially rectangular lid unit ( 15 ) that extends from a box wall ( 21 ) and folds to form a lid ( 19 ) with a flap ( 17 ) that tucks into the base unit box ( 16 ).
- the base unit box has an open top and a folded-closed bottom.
- the base unit box is a rectangular prism, with two short sides ( 26 ) and a front long side ( 34 ) and a back long side ( 21 ).
- the lid unit portion of the paperboard extends from the top of the back long side of the base unit box once it is folded to form a crease ( 20 ) at the attached part of the lid.
- the edge of the rectangular lid unit opposite the side that folds along the long side of the base unit folds down ( 18 ) to become a lid flap ( 17 ), to conveniently hold the lid in place.
- the substantially rectangular base unit ( 16 ) has a second 90° fold across its long side ( 20 ) to form the top long side of a base unit box that creases to form the extending lid, and a third 90° fold ( 24 ) parallel to the first fold that forms the bottom long side of the base unit box and sets the depth of the box.
- the depth of the box is preferably a multiple M of the depth, D of the narrow opening of the sleeves of the package according to the invention.
- the third fold ( 24 ) has slits ( 23 ) from the outside of the base unit box to the outer edge of the unfolded base unit at either end of the third fold.
- This fourth fold also has slits ( 29 ) from the outside of the base unit box bottom to the outer edge of the unfolded base unit at either end of the fourth fold ( 33 ); these slits also become tabs ( 30 ) that help support the shape of the box.
- the spacing between the slit beginnings determine the length of the base unit box bottom ( 24 , 33 ) and are preferably a multiple N of one rectangular edge length L of the folded sleeve of the package for unitary dosage items.
- These slits form a tab ( 30 ) that folds 90° toward the inside of the box prior to folding up the base unit box sides to become side-supporting tabs.
- the tabs ( 22 , 30 ) are folded, two remaining center sections ( 26 ) are left on opposite sides of the bottom.
- the spacing between the slits of the second and third folds defines the width of the base unit box which should be a multiple P of the other rectangular edge W of the folded sleeve of the package for unitary dosage items.
- the fourth 90° fold parallel to the first, second and third folds forms the bottom front long side of the base unit box.
- the two remaining center sections ( 26 ) fold up 90° from the short sides of the base of the base unit box, typically with the side-supporting tabs ( 22 , 30 ) inside.
- the sides of the base unit box ( 26 ) are twice the height of the base unit box depth.
- the sides form bottom box corners at the ends of the third and fourth fold slits ( 23 , 29 ).
Landscapes
- Engineering & Computer Science (AREA)
- Mechanical Engineering (AREA)
- Packages (AREA)
Abstract
The present invention provides an alternative solution to packaging for a plurality of unitary dosage items that is convenient for a user to carry with them. Preferably, the easily portable package contains a number of unitary dosage items that will remind a user of which dosages have been administered. The present invention is particularly useful for unitary dosages of items whose stability or shelf life may be enhanced by decrease of exposure to degradative influences, such as light, oxygen or physical destruction.
Description
- The present invention provides packaging for unitary dosage items, such as capsules or tablets in a blister pack, where each sheet of the blister pack is individually wrapped in a paperboard sleeve to form an easily portable unit. Several of these portable units are packaged in a box for the consumer. Such packaging is particularly useful for oxygen- and light-sensitive dosage items, for example, omega-3-fatty acid, vitamin D, flax oil or conjugated linoleic acid nutritional supplements.
- Large bottles of pills, tablets and capsules are difficult to conveniently carry around with a person. This presents a problem, particularly when they need to take a unit dosage several times a day. Patient compliance is higher when it is easier for the person to take their dose of a medication. Pill boxes have existed for a very long time, for people to conveniently carry.
- Reminder pill boxes are also known, such as a container with 7 compartments labeled with the days of the week, so a person can remember whether they took their dosage for the day. Other pill boxes have multiple compartments within each day so that a person can tell whether they took a given unit dosage for a certain time of day. The pills in pill boxes of the art are exposed to air and light as they are transferred from a reservoir bottle to the pill box, and they can contact each other, possibly breaking, while the pill box is shaken with the motion of transporting the pill box with a person.
- Protective packaging for pills and tablets most commonly includes bottles where multiple pills and tablets are jumbled into a single bottle, often with cottony fill at the top and a lid. In some cases, the patient has difficulty opening a pill bottle, or difficulty in handling a large, cumbersome bottle. This type of packaging is somewhat limiting for breakable, fragile pills and capsules.
- A single container holding several doses with one opening lid also leads to a shorter shelf life for oxygen-sensitive pills and capsules. In this case, oxygen-sensitive means that the ingredients of the pills or capsules are more rapidly degraded over time upon exposure to oxygen than non-oxygen-sensitive pills or capsules. Each time the bottle is opened to remove a single dose, the remainder of product is exposed to oxygen in advance of its own consumption, often multiple times.
- Dosage-reminder packaging for tablets or capsules is known in the art. Several types of dosage-reminding packaging are blister packages with a certain arrangement of pills or capsules on the card, including some with labeling on the package for date or time for taking a particular pill or capsule. An example is the monthly package for birth control pills.
- Blister packaging is known to protect oxygen-sensitive tablets or capsules. The entire enclosure for the tablet or capsule should be impermeable to oxygen. This typically includes both the formed film side (often shaped to receive the tablet or capsule) and the sealing membrane side (typically planar).
- Some pills, tablets and capsules are fragile and can be physically damaged during storage and transport. For example, oral unit dosages of liquids are sometimes enclosed in a capsule. These liquid capsules may leak in storage if they get crushed. Pills or tablets may also be fragile or subject to damage by crushing or contact during transport and storage.
- Blister packaging itself can provide some protection against crushing. A problem with some blister packaging, particularly press-release types, is that the packaged unit dosage may be released during storage or transport if the blister package is subject to some physical stress, such as folding or physical pressure.
- Some medications or nutrients are sensitive to light. For example, the active ingredient can be degraded upon exposure to light of a certain wavelength. In the art, this problem is often minimized by using a dark-tinted bottle for medication or nutrient storage. In some cases, a protective coating that lets through less light is provided for the medication, on the unit dosage itself (e.g. opaque capsules).
- The present invention provides an alternative solution to the problem of stability of unit-dose blister packaging, while also solving the problem of easy portability and protection of fragile, oxygen-sensitive or light-sensitive pills or capsules.
- The present invention contemplates a convenient package for unitary dosage items that permits relatively small amounts of fragile or sensitive nutrients or medication to be easily portable. The package is a typical blister package made up of a polymeric layer with indentations for a plurality of unitary dosage items that is sealed in with a substantially planar adhesive layer that seals off each indentation, resulting in a plurality of individual compartments, each containing a unitary dosage of the unitary dosage items. The blister package may provide protection of each unitary dosage item from exposure to oxygen prior to use by the consumer. The blister package slides into a paperboard sleeve for physical protection of the blister package and the items contained therein. The invention optionally contemplates that the paperboard sleeve can provide a light barrier for light sensitive unitary dosage items. The package according to the present invention includes the paperboard sleeve together with the blister package that encloses the unitary dosage items.
- In some contemplated embodiments of a package for unitary dosage items according to the present invention, the package is particularly useful for the physical protection of fragile unitary dosage items. A contemplated fragile unitary dosage item is a gel cap containing a liquid nutritional supplement or a pharmaceutical active ingredient. One such contemplated unitary dosage item is a gel cap containing an edible oil and a nutritional supplement or a pharmaceutical active ingredient. Some of the contemplated nutritional supplements or pharmaceutical active ingredients include a polyunsaturated fatty acid compound having a
carbon chain 16 carbons in length where at least one pair of double bonds in that chain are in a conjugated position, vitamin D, flax oil, the polyunsaturated fatty acid that is conjugated linoleic acid, the flax oil component that is omega-3 fatty acid. - In a contemplated embodiment, the blister package contains a convenient number of unitary dosage items to provide a reminder to the consumer as to whether a particular dose has been taken or when the next dose should be taken.
- Also contemplated is the sale of a box containing a plurality of the described packages for unitary dosage items, where the width of the box is a multiple W of a side of the rectangle of the described protective sleeve and the length of the box is a multiple L of the other side of the protective sleeve and the depth of the box is a multiple D of the narrow opening of the sleeves that is basically the depth of the blister pack, so that the box able to hold at most a plurality of packages that is the multiple of W times L times D.
- There are several advantages and benefits of the present invention:
- It is an advantage of the present invention that an inner unit package of the present invention is easily personally portable.
- It is a benefit of the present invention that an inner unit package of the present invention contains several unit dosages of the pill or capsules to last for a short period of time.
- It is an advantage of present invention that the sleeve of the inner unit package provides a shield for light-sensitive pills or tablets to prolong their stability.
- It is a benefit of the present invention that the outer package is of a convenient size and that it contains several easily portable inner unit packages.
- It is an advantage of the present invention that the sleeve of the inner unit package provides protection against physical destruction (e.g. crushing or breakage) of the pills or tablets.
- In the drawings forming part of the present disclosure:
-
FIG. 1 represents inFIG. 1A an elevated view of an inner blister pack of a shaped sheet with recesses shaped to receives the pills or capsules in dosage amounts, and an essentially planar sheet that seals the pills or capsules into the recesses.FIG. 1B shows the blister pack in position inside the sleeve. -
FIG. 2 represents an inner sleeve formed out of a folded, single sheet of paperboard.FIG. 2A shows an overhead view of the single sheet that is folded and glued along 10 and 11 to form a paperboard sleeve, as shown inedges FIG. 2B from an elevated view. -
FIG. 3 represents an outer box formed out of a folded, single sheet of paperboard.FIG. 3A shows an overhead view of the single sheet that is folded to form the outer box as shown inFIG. 3B from an elevated view. - The present invention provides an alternative solution to packaging for a plurality of unitary dosage items that is convenient for a user to carry with them. Preferably, the easily portable package contains a number of unitary dosage items that will remind a user of which dosages have been administered. The present invention is particularly useful for unitary dosages of items whose stability or shelf life may be enhanced by decrease of exposure to degradative influences, such as light, oxygen or physical destruction.
- The present invention contemplates a package for a plurality of unitary dosage items that is a blister package. The blister package is constructed using methods and materials known in the art. An example is shown in
FIG. 1 . According to the language used in the present description, such blister packages typically comprise a polymeric layer that is substantially a planar rectangle with a plurality of indentations of regular depth for storing said unitary dosage items. There is also a substantially planar rectangular sealing layer of about the same size as the polymeric layer. The sealing layer adheres to the planar regions of the polymeric layer, thereby sealing off each indentation. An example of a blister package (1) is shown inFIG. 1A ;FIG. 1B shows the blister package inserted into the sleeve (5). - The present invention further contemplates a protective sleeve for the blister package, an example of which is shown in
FIG. 2 . The paperboard sleeve is constructed using methods and materials known in the art. In an example of convenient paperboard sleeve construction, a rectangular prismatic paperboard sleeve (5) is made up of a single sheet of substantially rectangular paperboard. The paperboard is folded four times (6, 7, 8, 9) with two opposing sides of the rectangle adhered together to form a sleeve that has substantially rectangular sides, two wide and two narrow in opposed pairs, with two substantially rectangular openings on opposite ends of the sleeve from each other. The two wide sides of the sleeve are slightly wider than the substantially planar rectangle of the blister pack and the two narrow sides of the sleeve are slightly wider than the indentation depth of the blister pack. The slightly larger size of the sleeve permits the paperboard sleeve to encompass the blister pack to form the package for the plurality of unitary dosage items, but it should not be so much larger that the package does not remain in the sleeve during transportation. - Sleeve construction. Contemplated sleeves may also be constructed in multiple parts rather than folded from a single sheet.
- Sleeve material. Contemplated sleeves may also be constructed from cardstock or heavier cardboard, of various thicknesses, colors, weights, corrugation, or plastic. However, it should be noted that in embodiments for protecting from physical damage from shearing or crushing forces, stronger materials for sleeves are contemplated. In a contemplated embodiment, the paperboard sleeve is from 0.2 to 0.5 millimeters thick.
- For embodiments for protecting from damage from light, opaque materials are contemplated. In a contemplated light protecting embodiment, sleeve construction material blocks 50 percent or more of the sun's ultraviolet rays, preferably more than 80 percent, and in a particularly preferred embodiment, a contemplated material blocks 100 percent of the sun's ultraviolet rays.
- The unitary dosage items that would benefit from the contemplated packaging include liquids and solids including pastes and oils. Contemplated benefiting unitary dosage items include fragile items, such as capsules or tablets that may be crushed or burst. Contemplated benefiting unitary dosage items also include sensitive items, such as those sensitive to oxygen or light. Examples of such sensitive items include vitamin D, linoleic acid, particularly conjugated linoleic acid, flax oil or any of its long chain fatty acid oil components.
- A particular problem addressed by the present invention is that many of the forms of vitamin D commercially available are not bioavailable to a body. This has led to a great deal of confusion in the art pertaining to vitamin D, as to whether vitamin D shows beneficial effects to humans, and how much should be administered to show those beneficial effects. Workers with the present inventors have found that only a fresh form of vitamin D, as a pasty oil, has proven itself to show beneficial effects.
- Another particular problem addressed by the present invention is that the beneficial components of fatty acids have a short shelf life, going rancid or otherwise degrading rather quickly. Examples include omega-3 and omega-6 fatty acids, cod liver oil, fish oil, linoleic acid, conjugated linoleic acid, and flaxseed oil. The present invention permits the provision of a longer shelf life form of oils or their useful components, including fatty acids, by providing protection from light and oxygen; and also by permitting easy portability of unitary dosage amounts.
- For example, it is common for flax seed users to store the seeds in the refrigerator or freezer to prolong the shelf life, and then to put the seeds only on already-cooked foods or raw foods, since the cooking process degrades the beneficial oil components. Gel caps of flaxseed oil are presently sold in large jars.
- Contemplated unitary dosage items include pills or capsules (including gel caps and two-piece hard gel capsules) that includes a nutritional supplement or a pharmaceutical active ingredient; fragile items; items sensitive to oxygen; items sensitive to light; vitamin D; conjugated linoleic acid; omega-3 fatty acid; flax oil; cod liver oil, fish oil, and omega-6 fatty acid.
- In an embodiment of the present invention, preferred fatty acids contained in a unitary dosage item include eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), docosapentaenoic acid (DPA), and alpha linolenic acid (ALA), typically from fish or marine sources, flax seed, krill or algae. In an embodiment, preferred fatty acid concentrations in mg of EPA:DHA per gram of oil include 250:450; 200:600; 500:200 and 400:200. Typical capsule sizes include 250 mg, 500 mg, 600 mg, and 1000 mg. Typical pill or capsule ingredient sources or types include vegetarian, bovine, porcine, synthetic and chewable.
- In an embodiment of the present invention, excipients include those well known in the art, typically emulsifiers such as lecithin and beeswax; stabilizers such as vitamin E, tocopherols, ascorbyl palmitate, and rosemary extract; and coloring agents including natural coloring agents such as annatto (for example in the capsule coating). Other contemplated additives include: minerals, including magnesium, zinc, chromium, calcium and selenium; vitamins, including beta-carotene, vitamin A, vitamin D, vitamin E, and vitamin B-complex; and nutraceuticals, including lutein, zeaxanthin, and resveratrol.
- In a contemplated embodiment, the packaging provides a convenient reminder of when pills have been or should be taken, or a convenient number of doses. For example, in a contemplated embodiment where the dose should be taken once each day, convenient packaging may provide a package where each row of the blister package contains 7 indentations for storing one week's worth of unitary dosage items. The number of rows may correspond to the number of weeks in a month. Or, if multiple doses are to be taken in a single day, a contemplated embodiment has rows representing different times of day, and a weeks worth of columns. It is to be understood that each dosage amount and frequency will dictate a variety of convenient arrangements of doses in a single blister pack. For example, in an embodiment where two unitary dosage items are to be taken each day, and each row of the blister package contains 14 indentations of regular depth for storing one week's worth of unitary dosage items.
- In a contemplated embodiment, the blister package contains a convenient number of unitary dosage items to provide a reminder to the consumer as to whether a particular dose has been taken or when the next dose should be taken. Preferably the rows and columns of the blister package or the labeling thereupon provide a reminder to the consumer as to whether or not a particular unitary dosage item has been consumed. For example, a blister pack may have a row containing seven indented chambers for a unitary dosage items that should be taken once a day. The blister pack may then have from one to four such rows to provide sufficient conveniently portable doses for a week or a month. In another example, a unitary dosage item should be taken three times each day. Then it may be convenient to provide a blister package that has three rows containing seven doses, so that each day, one dose is taken from each of the three rows.
- In order to provide a convenient dosage amount in a convenient-sized package, in a contemplated embodiment, a package for a plurality of unitary dosage items according the present invention is stacked together with a number of like packages inside an outer package. The outer package is constructed by any of the many known methods common in the art. Simple boxes for holding several contemplated packages for a plurality of unitary dosage items are contemplated, preferably sized to hold a number of packages that are convenient for the end-user. Dispenser packages are also contemplated that permit simple removal of a single contemplated package for a plurality of unitary dosage items.
- In an embodiment with an outer package that is a simple box, the outer package is conveniently constructed of a folded single piece of paperboard that has a substantially rectangular base unit that folds to form a base unit box (16). This embodiment is conveniently illustrated in
FIG. 3 . In an embodiment, the box lid is a self-lid, which is a substantially rectangular lid unit (15) that extends from a box wall (21) and folds to form a lid (19) with a flap (17) that tucks into the base unit box (16). In this description of such a box with unitary construction, the base unit box has an open top and a folded-closed bottom. In a typical embodiment, the base unit box is a rectangular prism, with two short sides (26) and a front long side (34) and a back long side (21). In the most common of those typical embodiments, the lid unit portion of the paperboard extends from the top of the back long side of the base unit box once it is folded to form a crease (20) at the attached part of the lid. The edge of the rectangular lid unit opposite the side that folds along the long side of the base unit folds down (18) to become a lid flap (17), to conveniently hold the lid in place. In its folded form, the substantially rectangular base unit (16) has a second 90° fold across its long side (20) to form the top long side of a base unit box that creases to form the extending lid, and a third 90° fold (24) parallel to the first fold that forms the bottom long side of the base unit box and sets the depth of the box. The depth of the box is preferably a multiple M of the depth, D of the narrow opening of the sleeves of the package according to the invention. To form convenient tabs (22, 30) for holding the shape of the box, the third fold (24) has slits (23) from the outside of the base unit box to the outer edge of the unfolded base unit at either end of the third fold. These tabs (22) fold 90° toward the inside of the box prior to folding up the base unit box sides to become side-supporting tabs. A fourth fold (33) parallel to the second and third folds becomes the bottom long side of the base unit box. This fourth fold also has slits (29) from the outside of the base unit box bottom to the outer edge of the unfolded base unit at either end of the fourth fold (33); these slits also become tabs (30) that help support the shape of the box. The spacing between the slit beginnings determine the length of the base unit box bottom (24, 33) and are preferably a multiple N of one rectangular edge length L of the folded sleeve of the package for unitary dosage items. These slits form a tab (30) that folds 90° toward the inside of the box prior to folding up the base unit box sides to become side-supporting tabs. When the tabs (22, 30) are folded, two remaining center sections (26) are left on opposite sides of the bottom. The spacing between the slits of the second and third folds defines the width of the base unit box which should be a multiple P of the other rectangular edge W of the folded sleeve of the package for unitary dosage items. The fourth 90° fold parallel to the first, second and third folds forms the bottom front long side of the base unit box. The two remaining center sections (26) fold up 90° from the short sides of the base of the base unit box, typically with the side-supporting tabs (22, 30) inside. As shown inFIG. 3 , in a very stable outer package embodiment, the sides of the base unit box (26) are twice the height of the base unit box depth. The sides form bottom box corners at the ends of the third and fourth fold slits (23, 29). A final fold (27) of the portion of the short sides of the base unit box that extends up above the base unit box depth 180° down, preferably over the side-supporting tabs, adds further shape stability. These folded down side flaps are either glued down, or small tabs (35) at the outer edge slipped into slits (36) at the box side bottom fold lines, as shown in the drawing. The side height after folding is only once the height of the base unit box depth. Thus is formed a rectangular base unit box that is closed at the bottom and open at the top that can hold a stacked plurality that is the multiples of L, W and D of the packages for unitary dosage items.
Claims (14)
1. A package for a plurality of unitary dosage items comprising:
a. a blister package comprising a polymeric layer that is substantially a planar rectangle with a plurality of indentations of regular depth for storing said unitary dosage items; and a substantially planar rectangular sealing layer of about the same size as the polymeric layer, wherein the sealing layer adheres to the planar regions of the polymeric layer, thereby sealing off each indentation; and
b. a paperboard sleeve comprising a single sheet of substantially rectangular paperboard folded four times with two opposing sides of the rectangle adhered together to form a sleeve that has substantially rectangular sides, two wide and two narrow in opposed pairs, and two substantially rectangular openings on opposite ends of the sleeve from each other, wherein the two wide sides of the sleeve are slightly wider than the substantially planar rectangle of the blister pack and the two narrow sides of the sleeve are slightly wider than the indentation depth of the blister pack;
thereby permitting the paperboard sleeve to encompass the blister pack to form the package for the plurality of unitary dosage items.
2. The package according to claim 1 wherein said unitary dosage items are gel caps containing a liquid that includes a nutritional supplement or a pharmaceutical active ingredient.
3. The package according to claim 2 wherein said unitary dosage item is fragile.
4. The package according to claim 2 wherein said unitary dosage item is sensitive to oxygen.
5. The package according to claim 2 wherein said unitary dosage item is sensitive to light.
6. The package according to claim 4 wherein said unitary dosage item is vitamin D.
7. The package according to claim 5 wherein said unitary dosage item is conjugated linoleic acid.
8. The package according to claim 4 wherein said unitary dosage item is omega-3 fatty acid.
9. The package according to claim 4 wherein said unitary dosage item is flax oil.
10. The package according to claim 1 wherein said paperboard sleeve is opaque to light.
11. The package according to claim 1 wherein said paperboard sleeve is from 0.2 to 0.5 millimeters thick.
12. The package according to claim 1 wherein said unitary dosage item is to be taken once each day, and each row of the blister package contains 7 indentations of regular depth for storing one week's worth of unitary dosage items.
13. The package according to claim 1 wherein two unitary dosage items are to be taken each day, and each row of the blister package contains 14 indentations of regular depth for storing one week's worth of unitary dosage items.
14. The package according to claim 1 that is stacked together with a plurality of other packages according to claim 1 inside an outer package that comprises a folded single piece of paperboard that has a substantially rectangular base unit that folds to form a base unit box and an extension that is a substantially rectangular lid unit that folds to form a lid with a flap that tucks into the base unit box; wherein said base unit box has an open top and a closed bottom with two short sides and a front long side and a back long side, wherein said lid unit extends from the top of the back long side of the base unit box once it is folded to form a crease at the attached part of the lid, and the edge of the rectangular lid unit opposite the side that folds along the long side of the base unit folds down to become a lid flap; and wherein the substantially rectangular base unit has a first 90° fold across its long side to form the top long side of a base unit box that creases to form the extending lid, and a second 90° fold parallel to the first fold that forms the bottom long side of the base unit box and setting the depth of the box, said depth being a multiple D of the narrow opening of the sleeves recited in claim 1 , said second fold having slits from the outside of the base unit box to the outer edge of the unfolded base unit at either end of the second fold, which fold 90° toward the inside of the box prior to folding up the base unit box sides to become side-supporting tabs, and a third fold parallel to the first and second folds that become the bottom long side of the base unit box, said third fold having slits from the outside of the base unit box bottom to the outer edge of the unfolded base unit at either end of the third fold, wherein the spacing between the slit beginnings determine the length of the base unit box bottom and are a multiple of the length L of one rectangular edge of the folded sleeve of the package described in claim 1 , and which slits form a tab that folds 90° toward the inside of the box prior to folding up the base unit box sides to become side-supporting tabs and leaving two remaining center sections on opposite sides of the bottom wherein the spacing between the slits of the second and third folds defines the width of the base unit box which should be a multiple W of the other rectangular edge of the folded sleeve of the package described in claim 1 , and a fourth 90° fold parallel to the first, second and third folds that forms the bottom front long side of the base unit box; the two remaining center sections fold up 90° from the short sides of the base of the base unit box outside of the side-supporting tabs, being twice the height of the base unit box depth, forming bottom box corners at the ends of the second and third fold slits, a final fold of the short sides of the base unit box down over the side-supporting tabs so that the side height is only once the height of the base unit box depth, thereby forming a rectangular base unit box that is closed at the bottom and open at the top that can hold a stacked plurality that is the multiple of L times W times D of the packages according to claim 1 .
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11/985,710 US20090127155A1 (en) | 2007-11-16 | 2007-11-16 | Packaging for unitary dosage items |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11/985,710 US20090127155A1 (en) | 2007-11-16 | 2007-11-16 | Packaging for unitary dosage items |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| US20090127155A1 true US20090127155A1 (en) | 2009-05-21 |
Family
ID=40640794
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US11/985,710 Abandoned US20090127155A1 (en) | 2007-11-16 | 2007-11-16 | Packaging for unitary dosage items |
Country Status (1)
| Country | Link |
|---|---|
| US (1) | US20090127155A1 (en) |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20090230013A1 (en) * | 2008-03-17 | 2009-09-17 | The Procter & Gamble Company | User-Customizable Dosing System |
| US20090236303A1 (en) * | 2008-02-04 | 2009-09-24 | Lizerbram Eric K | Container closure with additive reservoir |
| US9027786B2 (en) | 2010-12-08 | 2015-05-12 | Mark C. Doyle | Packaging systems and methods |
| US9351907B2 (en) | 2011-07-19 | 2016-05-31 | Id-Con, Llc | Packaging systems and methods |
| US11312560B1 (en) * | 2019-11-22 | 2022-04-26 | Pamela Johnson | Storage bin for light sensitive medication |
| US12208952B2 (en) | 2022-05-31 | 2025-01-28 | Sonoco Development, Inc. | Paper blister |
Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3112058A (en) * | 1961-10-30 | 1963-11-26 | Carborundum Co | End opening box with self-locking cover and blank for forming the same |
| US4168028A (en) * | 1978-05-19 | 1979-09-18 | Mack-Chicago Corporation | Shipping box for coats |
| US4656066A (en) * | 1982-12-20 | 1987-04-07 | Warner-Lambert Company | Apparatus and method for sealing capsules |
| US5325968A (en) * | 1993-07-14 | 1994-07-05 | Mcneil-Ppc, Inc. | Package for holding tablets |
| US5685420A (en) * | 1995-03-31 | 1997-11-11 | Johnson & Johnson Vision Products, Inc. | Composite packaging arrangement for contact lenses |
| US6273260B1 (en) * | 2000-03-08 | 2001-08-14 | Eli Lilly And Company | Pharmaceutical packaging system |
| US6375956B1 (en) * | 1999-07-22 | 2002-04-23 | Drugtech Corporation | Strip pack |
| US20050103677A1 (en) * | 2002-03-13 | 2005-05-19 | Pablo Fuchsberger | Pack for medicine in capsule, pill or similar form |
-
2007
- 2007-11-16 US US11/985,710 patent/US20090127155A1/en not_active Abandoned
Patent Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3112058A (en) * | 1961-10-30 | 1963-11-26 | Carborundum Co | End opening box with self-locking cover and blank for forming the same |
| US4168028A (en) * | 1978-05-19 | 1979-09-18 | Mack-Chicago Corporation | Shipping box for coats |
| US4656066A (en) * | 1982-12-20 | 1987-04-07 | Warner-Lambert Company | Apparatus and method for sealing capsules |
| US5325968A (en) * | 1993-07-14 | 1994-07-05 | Mcneil-Ppc, Inc. | Package for holding tablets |
| US5685420A (en) * | 1995-03-31 | 1997-11-11 | Johnson & Johnson Vision Products, Inc. | Composite packaging arrangement for contact lenses |
| US6375956B1 (en) * | 1999-07-22 | 2002-04-23 | Drugtech Corporation | Strip pack |
| US6273260B1 (en) * | 2000-03-08 | 2001-08-14 | Eli Lilly And Company | Pharmaceutical packaging system |
| US20050103677A1 (en) * | 2002-03-13 | 2005-05-19 | Pablo Fuchsberger | Pack for medicine in capsule, pill or similar form |
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20090236303A1 (en) * | 2008-02-04 | 2009-09-24 | Lizerbram Eric K | Container closure with additive reservoir |
| US8152017B2 (en) * | 2008-02-04 | 2012-04-10 | Eric K. Lizerbram | Container closure with additive reservoir |
| US20090230013A1 (en) * | 2008-03-17 | 2009-09-17 | The Procter & Gamble Company | User-Customizable Dosing System |
| US9027786B2 (en) | 2010-12-08 | 2015-05-12 | Mark C. Doyle | Packaging systems and methods |
| US9351907B2 (en) | 2011-07-19 | 2016-05-31 | Id-Con, Llc | Packaging systems and methods |
| US11069433B2 (en) | 2011-07-19 | 2021-07-20 | Id-Con, Llc | Packaging systems and methods |
| US11312560B1 (en) * | 2019-11-22 | 2022-04-26 | Pamela Johnson | Storage bin for light sensitive medication |
| US12208952B2 (en) | 2022-05-31 | 2025-01-28 | Sonoco Development, Inc. | Paper blister |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2746940T3 (en) | Disposable soft contact lens containers having a preformed multilayer structural laminate | |
| RU2174487C2 (en) | Blister package, device of and method of making blister packages | |
| US20090127155A1 (en) | Packaging for unitary dosage items | |
| EP0148118B1 (en) | Package | |
| US3504788A (en) | Package | |
| US7909165B2 (en) | System for delivering sequential components | |
| ES2338474T3 (en) | ASSORTMENT OF PACKED PRODUCTS. | |
| US4189053A (en) | Bulk unit of use informational medicinal dispensing system | |
| ES2277650T3 (en) | CONTAINER TO DISPENSE. | |
| ES2367558T3 (en) | PELABLE BAG. | |
| CA2445234C (en) | Product packaging material for individual temporary storage of pharmaceutical products | |
| US20180153769A1 (en) | Child resistant blister card package | |
| US8191710B2 (en) | Packaging | |
| US10463569B2 (en) | Pharmaceutical package | |
| WO2007113850A1 (en) | A child resistant unit dose pack | |
| US20140360966A1 (en) | Dual compartment container for holding solid and liquid | |
| EP3452001B1 (en) | Device and method for packaging solid medicaments, device for storing and dispensing such medicaments, and dispensing method | |
| US20120248004A1 (en) | Method and apparatus for packaging and delivering nutraceutical, pharmaceutical, and polyceutical compositions | |
| ES2220761T3 (en) | CONTAINER FOR PASTRY OR LIQUID SUBSTANCES AND SETS OF CONTAINERS FOR THE SAME. | |
| US20040206653A1 (en) | Blister package with closable cavities and uses thereof | |
| JP2001070404A (en) | Mount for storing push-through pack (PTP) sheets | |
| US20040031718A1 (en) | Dispenser packaging | |
| US10442603B2 (en) | Pharmaceutical package | |
| JP2001046469A (en) | Blister pack | |
| JP6698295B2 (en) | Multipurpose sheet for pharmaceutical packaging and case base material for pharmaceutical packaging |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |